(Q67438199)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1253130%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

title

Decreased risk of radiation-associated second malignant neoplasms in actinomycin-D-treated patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1253130%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

Decreased risk of radiation-associated second malignant neoplasms in actinomycin-d-treated patients (English)

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

radiation-induced neoplasms

10 November 2023

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1253130

5 September 2022

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

10 November 2023

author name string

G. J. D'Angio

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1253130

5 September 2022

A. Meadows

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1253130

5 September 2022

V. Miké

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1253130

5 September 2022

C. Harris

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1253130

5 September 2022

A. Evans

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1253130

5 September 2022

N. Jaffe

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1253130

5 September 2022

W. Newton

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1253130

5 September 2022

O. Schweisguth

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1253130

5 September 2022

W. Sutow

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1253130

5 September 2022

P. Morris-Jones

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1253130

5 September 2022

language of work or name

English

0 references

publication date

1 February 1976

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1253130%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

13 September 2019

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%28197602%2937%3A2%20%3C1177%3A%3AAID-CNCR2820370829%3E3.0.CO%3B2-3

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1253130

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

10 November 2023

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

10 November 2023

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

10 November 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1253130%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1253130%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

issue

2 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1253130%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

page(s)

1177-1185

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1253130%20AND%20SRC:MED&resulttype=core&format=json

Nonlymphomatous malignant tumors complicating Hodgkin's disease. Possible association with intensive therapy

13 September 2019

cites work

1

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

10 November 2023

2

28

27

Bates

1968

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

In Vitro Cell Transformation by X-Irradiation

10 November 2023

3

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

Alteration of mutation frequency by treatment with actinomycin D

10 November 2023

4

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

Pediatric cancer in perspective: Cure is not enough

10 November 2023

6

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

The use of drugs in combination for the treatment of cancer: rationale and results

10 November 2023

8

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

Experimental evaluation of actinomycin D

10 November 2023

9

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

Adriamycin Activating a Recall Phenomenon After Radiation Therapy

10 November 2023

10

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

Neurofibromatosis in childhood

10 November 2023

11

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

10 November 2023

12

26

1349

Flamm

1966

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

SKIN TUMORIGENESIS BY 7,12-DIMETHYLBENZ(A)ANTHRACENE: INHIBITION BY ACTINOMYCIN D

10 November 2023

14

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

Inhibition of mouse skin tumorigenesis by actinomycin D

10 November 2023

15

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

Combination therapy of urogenital embryonal rhabdomyosarcoma in children

10 November 2023

16

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

Immunosuppressive Anticancer Drugs in Man: Their Oncogenic Potential

10 November 2023

18

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

Multiple cutaneous cancers in children: The nevoid basal cell carcinoma syndrome

10 November 2023

21

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

Retinoblastoma: epidemiologic characteristics

10 November 2023

24

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

The limit of renal tolerance to x-rays; an investigation into renal damage occurring following the treatment of tumours of the testis by abdominal baths

10 November 2023

26

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

Risk of second tumors in survivors of childhood cancer

10 November 2023

27

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

Estimation of Relative Risk from Individually Matched Series

10 November 2023

35

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

Multiple primary malignant neoplasms. I. Introduction and presentation of data

10 November 2023

36

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

Late effects of radiation: carcinogenesis

10 November 2023

37

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

Induction of intestinal carcinoma in the rat by x-irradiation of the small intestine

10 November 2023

38

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

INCIDENCE OF SECOND PRIMARY TUMORS IN CHILDREN WITH CANCER AND LEUKEMIA: A SEVEN-YEAR SURVEY OF 150 CONSECUTIVE AUTOPSIED CASES.

10 November 2023

41

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma

10 November 2023

42

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

Proceedings: Disease-free survival in children with Ewing's sarcoma treated with radiation therapy and adjuvant four-drug sequential chemotherapy

10 November 2023

43

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

Hodgkin's disease and acute leukemia. Report of eight cases and review of the literature

10 November 2023

44

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

Immunosuppressive and Cytotoxic Chemotherapy: Long-Term Complications

10 November 2023

46

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

“Total therapy” studies of acute lymphocytic leukemia in children. Current results and prospects for cure

10 November 2023

47

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

10 November 2023

49

30

2271

Svoboda

1970

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

Clinical experiences with actinomycins D, KS2, and F1 (KS4)

10 November 2023

50

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

Second primary neoplasms in children

10 November 2023

52

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

Exposure-response curve for radiation-induced lung tumors in the mouse

10 November 2023

54

1 reference

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197602)37:2+%3C1177::AID-CNCR2820370829%3E3.0.CO;2-3

10 November 2023

Identifiers

10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1253130%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

1 reference